Recombinant bacillus subtilis for displaying vibrio parahaemolyticus VP OmpK-MeL on spore surface, construction method and application
By constructing a recombinant Bacillus subtilis strain VPOmpK-MeL displaying Vibrio parahaemolyticus on its spore surface, the problem of the lack of highly effective oral vaccines in aquaculture has been solved. This approach achieves genetic stability and immune enhancement, simplifies the immunization procedure, and is suitable for the development of safe vaccines for small fish.
Patent Information
- Application Number
- CN202511945082.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-22
- Publication Date
- 2026-03-17
AI Technical Summary
There is a lack of highly effective and safe vaccines against Vibrio parahaemolyticus in current aquaculture, especially oral vaccines suitable for small fish. Furthermore, traditional vaccines have stability and safety issues, are difficult to administer, and have unstable protective effects.
A recombinant Bacillus subtilis spore surface displaying Vibrio parahaemolyticus VPOmpK-MeL was constructed. The OmpK antigen and MeL fusion protein were displayed on the surface of Bacillus subtilis spores using genetic engineering methods. Recombination was performed using the integrative plasmid pDG364 to ensure genetic stability. The spores were then transformed into B. subtilis 168 via homologous double cross transformation to achieve direct oral immunization.
This recombinant strain displays the VP OM protein on the spore surface, simplifying the immunization procedure, reducing costs, stimulating a specific immune response, enhancing the immune effect, protecting the intestinal barrier function, and reducing inflammatory response, making it suitable for commercial vaccine development.